SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-094137
Filing Date
2023-12-07
Accepted
2023-12-07 17:29:58
Documents
13
Period of Report
2023-12-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea189652-8k_biomxinc.htm   iXBRL 8-K 41658
  Complete submission text file 0001213900-23-094137.txt   264261

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE phge-20231207.xsd EX-101.SCH 3919
3 XBRL DEFINITION FILE phge-20231207_def.xml EX-101.DEF 26852
4 XBRL LABEL FILE phge-20231207_lab.xml EX-101.LAB 37202
5 XBRL PRESENTATION FILE phge-20231207_pre.xml EX-101.PRE 25476
7 EXTRACTED XBRL INSTANCE DOCUMENT ea189652-8k_biomxinc_htm.xml XML 5693
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 231473428
SIC: 2836 Biological Products, (No Diagnostic Substances)